Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial

Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-17T17:08:22.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a terminated trial of pembrolizumab, exemestane, and leuprolide for premenopausal patients with advanced breast cancer. It includes study eligibility, treatment details, outcomes, and record dates.
    Difference
    43%
    Check dated 2026-11-10T15:57:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer's displayed site revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:41:15.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the site navigation. The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:06:40.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T16:52:06.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site chrome (header/footer) instead of the study details; this indicates an access/permissions issue rather than a new feature or data update.
    Difference
    17%
    Check dated 2026-09-22T22:07:10.000Z thumbnail image

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.